Clinical pharmacology and economics of recombinant human erythropoietin in end-stage renal disease: the case for subcutaneous administration. - Besareb,A.; Flaharty,K.K.; Erslev,A.J.; McCrea,J.B.; Vlasses,P.H.; Medina,F. (J Am Soc Nephrol, 1992)